97 related articles for article (PubMed ID: 26875036)
1. [A pilot study to evaluate the DMP for coronary heart disease - Development of a methodology and first results].
Schulte T; Mund M; Hofmann L; Pimperl A; Dittmann B; Hildebrandt H
Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():54-9. PubMed ID: 26875036
[TBL] [Abstract][Full Text] [Related]
2. [Evaluating the effectiveness of a disease management program diabetes in the German Statutory Health Insurance: first results and methodological considerations].
Drabik A; Graf C; Büscher G; Stock S
Z Evid Fortbild Qual Gesundhwes; 2012; 106(9):649-55. PubMed ID: 23200208
[TBL] [Abstract][Full Text] [Related]
3. [General practitioners' perspectives on the perceived effectiveness of the disease management programs for type 2 diabetes and coronary heart disease: Results of a focus group study].
Pilic L; Molkentin K; Lehmann L; Herrmann A; Funke C; Müller BS; Bödecker AW; Redaèlli M; Wilm S
Z Evid Fortbild Qual Gesundhwes; 2024 Apr; 185():45-53. PubMed ID: 38418359
[TBL] [Abstract][Full Text] [Related]
4. [Integrated care for patients with heart failure in Switzerland: a cost analysis].
Eichler K; Krass A; Fendl A; Thüring N; Brügger U
Praxis (Bern 1994); 2009 Jul; 98(15):809-15. PubMed ID: 19642063
[TBL] [Abstract][Full Text] [Related]
5. Disease management programmes for patients with coronary heart disease--an empirical study of German programmes.
Gapp O; Schweikert B; Meisinger C; Holle R
Health Policy; 2008 Dec; 88(2-3):176-85. PubMed ID: 18442868
[TBL] [Abstract][Full Text] [Related]
6. Patients with type 2 diabetes benefit from primary care-based disease management: a propensity score matched survival time analysis.
Drabik A; Büscher G; Thomas K; Graf C; Müller D; Stock S
Popul Health Manag; 2012 Aug; 15(4):241-7. PubMed ID: 22401149
[TBL] [Abstract][Full Text] [Related]
7. Health system responsiveness and chronic disease care - What is the role of disease management programs? An analysis based on cross-sectional survey and administrative claims data.
Röttger J; Blümel M; Linder R; Busse R
Soc Sci Med; 2017 Jul; 185():54-62. PubMed ID: 28554159
[TBL] [Abstract][Full Text] [Related]
8. [Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)].
Szucs TD; Schwenkglenks M; Rutishauser W
Med Klin (Munich); 2000 Jan; 95(1):1-13. PubMed ID: 10668338
[TBL] [Abstract][Full Text] [Related]
9. Selective enrollment in Disease Management Programs for coronary heart disease in Germany - An analysis based on cross-sectional survey and administrative claims data.
Röttger J; Blümel M; Busse R
BMC Health Serv Res; 2017 Apr; 17(1):246. PubMed ID: 28372554
[TBL] [Abstract][Full Text] [Related]
10. Analysing horizontal equity in enrolment in Disease Management Programmes for coronary heart disease in Germany 2008-2010.
Bozorgmehr K; San Sebastian M; Brenner H; Razum O; Maier W; Saum KU; Holleczek B; Miksch A; Szecsenyi J
Int J Equity Health; 2015 Mar; 14():28. PubMed ID: 25879523
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Disease Management Programs for Cardiovascular Risk and COPD in The Netherlands.
Tsiachristas A; Burgers L; Rutten-van Mölken MP
Value Health; 2015 Dec; 18(8):977-86. PubMed ID: 26686781
[TBL] [Abstract][Full Text] [Related]
12. The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention.
Becker C; Holle R; Stollenwerk B
Health Policy; 2015 Jun; 119(6):778-86. PubMed ID: 25656962
[TBL] [Abstract][Full Text] [Related]
13. [Experiences with synopses of clinical guidelines using the example of synopses for Disease Management Programmes (DMP)].
Siering U; Rüther A
Z Evid Fortbild Qual Gesundhwes; 2014; 108(10):560-8. PubMed ID: 25499108
[TBL] [Abstract][Full Text] [Related]
14. [Costs of coronary heart diseases over the remaining life time in coronary heart disease cases--an analysis of the current status of coronary heart disease cases in Germany from the social perspective].
Klever-Deichert G; Hinzpeter B; Hunsche E; Lauterbach KW
Z Kardiol; 1999 Dec; 88(12):991-1000. PubMed ID: 10654390
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of German disease management programs (DMPs) in patients with type 2 diabetes mellitus and coronary heart disease: results from an observational longitudinal study.
Laxy M; Stark R; Meisinger C; Kirchberger I; Heier M; von Scheidt W; Holle R
Diabetol Metab Syndr; 2015; 7():77. PubMed ID: 26388948
[TBL] [Abstract][Full Text] [Related]
16. Exploring Health System Responsiveness in Ambulatory Care and Disease Management and its Relation to Other Dimensions of Health System Performance (RAC) - Study Design and Methodology.
Röttger J; Blümel M; Engel S; Grenz-Farenholtz B; Fuchs S; Linder R; Verheyen F; Busse R
Int J Health Policy Manag; 2015 May; 4(7):431-7. PubMed ID: 26188807
[TBL] [Abstract][Full Text] [Related]
17. Life prolonging of disease management programs in patients with type 2 diabetes is cost-effective.
Drabik A; Büscher G; Sawicki PT; Thomas K; Graf C; Müller D; Stock S
Diabetes Res Clin Pract; 2012 Feb; 95(2):194-200. PubMed ID: 22004943
[TBL] [Abstract][Full Text] [Related]
18. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
Fidan D; Unal B; Critchley J; Capewell S
QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
[TBL] [Abstract][Full Text] [Related]
19. [General practitioners' opinion and attitude towards DMPs and the change in practice routines to implement the DMP "diabetes mellitus type 2"].
Miksch A; Trieschmann J; Ose D; Rölz A; Heiderhoff M; Szecsenyi J
Z Evid Fortbild Qual Gesundhwes; 2011; 105(6):427-33. PubMed ID: 21843845
[TBL] [Abstract][Full Text] [Related]
20. A prospective examination of disease management program use by complex cardiac outpatients.
Gravely S; Reid RD; Oh P; Ross H; Stewart DE; Grace SL;
Can J Cardiol; 2012; 28(4):490-6. PubMed ID: 22424663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
